ASX Announcements, Company News 25 Mar 2024 Orthocell Successfully Completes Surgeries for Remplir™ US Market Authorisation Orthocell has announced that it has successfully completed the first stage of the Remplir™ US 510(k) market authorisation nerve repair… Orthocell